Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05013073 · ClinicalTrials.gov registry record · NA
ASTHMAXcel Emergency Department Study
A NA study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT05013073 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 160 participants.
The verdict
NCT05013073, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.
Interventions
- OTHER ASTHMAXcel ED Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2023-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05013073
The ClinicalTrials.gov registry entry for NCT05013073 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASTHMAXcel ED Application is the first listed.
NCT05013073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05013073 about?
NCT05013073 is a clinical study titled "ASTHMAXcel Emergency Department Study". This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.
What is the current status of trial NCT05013073?
This trial is currently terminated. It is a NA study. The enrollment target is 160 participants. The study started on 2021-05-01. Estimated completion is 2023-02-07.
What interventions are being tested in trial NCT05013073?
The interventions under investigation include: ASTHMAXcel ED Application (OTHER).
Who is sponsoring clinical trial NCT05013073?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.